Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor Arturo Reyes-Sandoval (Nuffield Department of Clinical Medicine) was awarded Medical Research Council Confidence in Concept funding for his project to develop a new vaccine against dengue fever. Listen to him speak about his research and experience of funding.

 Interview transcript 

project overview

Dengue virus infects 400 million people a year, and is a leading cause of illness and death in the tropics and subtropics. Professor Reyes-Sandoval and his team had already developed vaccine candidates for this virus, and this project focused on testing their efficacy through collaborations with a team in Brazil. 

researcher profile

Arturo Reyes-SandovalProfessor Arturo Reyes-Sandoval

Associate Professor

Jenner Institute, Nuffield Department of Clinical Medicine  



The MRC Confidence in Concept Fund awarded £50k to this translational project to develop a dengue virus vaccine between October 2015 and August 2016. The panel felt the team was strong, and collaboration with Brazilian researchers was key as Brazil is a major dengue market. There was good potential that outcomes would lead to Developmental Pathway Funding Scheme application to the MRC and/or pilot data to support clinical studies. 

related links

Nuffield Department of Clinical Medicine

The Jenner Institute

Arturo Reyes-Sandoval discusses his work on a vaccine for P. vivax malaria